Skip to main content

West Pharmaceutical Services Value Stock - Dividend - Research Selection

West Pharmaceutical Services

ISIN: US9553061055, WKN: 864330

Market price date: 23.07.2021
Market price: 381,07 USD

West Pharmaceutical Services Fundamental data and company key figures of the share

Annual reports in USD
Key figures 12-04-2021
Cash flow
Net operating cash flow 472.000.000
Capital Expenditures -174.400.000
Free cash flow 297.600.000
Balance sheet
Total Equity 1.854.500.000
Liabilities & Shareholders equity 2.793.000.000
Income statement
Net income 346.000.000
Eps (diluted) 4,570
Diluted shares outstanding 75.800.000
Net sales/revenue

Fundamental ratios calculated on: 23-07-2021

Key figures 23-07-2021
Cash flow
P/C 61,20
P/FC 97,06
Balance sheet
Income statement
Div. Yield0,00%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization28.885.106.688,00 USD
IndicesS&P 500
Raw Data SourceUS GAAP in Millionen USD
Stock Split2013-09-27,2.000000/1.000000; 2004-09-30,2.000000/1.000000; 2004-09-29,2.000000/1.000000; 1987-06-02,2.000000/1.000000; 1982-05-06,2.000000/1.000000

Description of the company

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,